MMC Ventures’ Post

Of the 691 million scans performed at hospitals last year, many revealed potentially cancerous abnormalities, yet 70% lacked proper follow-up. This gap leaves millions with undiagnosed cancer, underscoring a critical issue in healthcare. To better understand this issue, we sat down with four oncology leaders to see how they are using AI to catch cancer early and centralize care coordination, leading to tremendous outcomes, both clinically and financially. If you’re looking to champion stage shift in 2024, check out our blog to see how AI is transforming early detection programs across the nation. #Oncology #AI #EarlyCancerDetection #HealthTech #DefyDisease #CancerMoonshot

Timely cancer diagnosis is critical, but current methods often lead to unnecessary testing delays. 🔬🥼💊🧬💉 However, advances in prostate cancer testing, like PSA isoform analysis, offer improved specificity, reducing unnecessary biopsies by up to 55%. This fresh article by Cleveland Diagnostics, Inc.'s Bob Rochelle, MBA, highlights the largest barriers to effective screening and the impact of ineffective testing methods on the healthcare systems. Check it out here!👇 https://lnkd.in/epFkWU6Q #CancerResearch #EarlyDetection #CancerTesting #WasteManagement #Resources #USHealthcare

AI-Powered diagnostic tool now in NCCN Guidelines #medicaltechnology 🤝 Follow us on Discord 🔜: https://lnkd.in/gt823Zd3 🤝 Follow us on Whatsapp 🔜 https://wapia.in/wabeta _ ❇️ Summary: ArteraAI's AI-powered Prostate Test has been included in the NCCN Clinical Practice Guidelines for Prostate Cancer, making it the first AI-enabled predictive and prognostic tool recommended for localized prostate cancer management. The test's predictive and prognostic capabilities set a new standard in oncology, with Level IB evidence supporting its effectiveness. This achievement signifies a significant milestone in integrating AI technologies into clinical practice, paving the way for future AI-powered diagnostic tools in personalized patient care and promising more precise and effective treatments for cancer patients globally. Hashtags: #chatGPT #AIpowereddiagnostics #NCCNguidelines

Coverage based on the inputs shared by Dr Aruj Dhyani, Consultant- Medical Oncology, Fortis Hospital, Noida   Publication: Financial Express   Topic: High-grade vs low-grade cancer: Read on to know what’s the difference, symptoms and treatment

#AI is transforming cancer care by enabling precise, personalized treatments for your patients, making it a more manageable disease. Read more about how data-driven medicine will become the standard of care for patients facing cancer and rare diseases: https://bit.ly/46xHjuF #Oncology #AIinHealthcare #CancerTreatment

📢Eye-Opening Study Alert! The latest research, featuring Dr. Divya from HHPR and team, uncovers striking differences in how oncologists handle end-of-life cancer care. Patients treated by certain oncologists were 4x more likely to receive therapy in their final days. This highlights a crucial opportunity to enhance patient care by addressing these variations. #hhpr #uark https://lnkd.in/gEhEThdY

Researchers unveil an AI-based Cancer Survival Calculator for precise patient-specific survival predictions #AI #AIpoweredtool #artificialintelligence #Breastcancer #cancercenters #CancerSurvivalCalculator #clinicalpracticeintegration #Healthcare #influentialfactors #llm #longtermsurvivalpredictions #machinelearning #NationalCancerDatabase #PancreaticCancer #patientspecificestimates #personalizedoutlook #pilottests #predictiveprowess #thyroidcancer #treatmentdetails #tumorbiomarkers #userinterface

Advancing Early Cancer Detection: A Paradigm Shift in Healthcare Early cancer identification can significantly improve patient outcomes and reduce healthcare costs. Eric Topol's editorial elegantly highlights the potential of ctDNA technologies to significantly reduce cancer-related mortality, provided they can address the challenges of early-stage detection and false positives. Read the full editorial here: https://lnkd.in/eGfKFDWU #CancerDetection #HealthcareInnovation #Oncology #EarlyDetection #MedicalResearch

"If adopted widely, 89Zr-TLX250 PET-CT imaging could become a new standard in kidney cancer diagnostics, like how PET-CT imaging has revolutionized prostate cancer management. It could also aid in the detection of other types of kidney cancers and help monitor patients at high risk of metastasis." #PETCT #medicalimaging #cancer #kidneycancer #noninvasiveimaging #health #healthcare

Unlock the insights on the potential impacts of Covid-19 JN.1 variant on cancer patients by Dr. Sumant Gupta, Director - Metro Cancer Institute, Faridabad. Explore the article, recently published in ETHealthworld, for expert perspectives. https://lnkd.in/gYW-uU4D #Covid19Variant #CancerCare #ExpertInsights #ETHealthworld #MetroHospitals #MetroGroup #DrSumantGupta